Predictive Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.5%.

Top 25 shareholders own 16.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.13%	Intracoastal Capital LLC	205,501	€1.2m	0%	no data
2.66%	The Vanguard Group, Inc.	106,401	€599.6k	0%	no data
2.61%	Carl Schwartz	104,585	€589.4k	0%	no data
0.85%	Charles Nuzum	34,033	€191.8k	17.4%	no data
0.81%	Geode Capital Management, LLC	32,301	€182.0k	0%	no data
0.52%	RB Capital Management, LLC	20,834	€117.4k	161%	0.04%
0.46%	J. Engle	18,421	€103.8k	-11.6%	no data
0.4%	Gregory St. Clair	16,059	€90.5k	45.9%	no data
0.38%	Nancy Chung-Welch	15,085	€85.0k	31.3%	no data
0.32%	Daniel Handley	12,790	€72.1k	39.1%	no data
0.31%	State Street Global Advisors, Inc.	12,236	€69.0k	0%	no data
0.26%	Carnegie Mellon University Endowment Arm	10,357	€58.4k	0%	0.04%
0.26%	Renaissance Technologies LLC	10,315	€58.1k	-31.9%	no data
0.18%	Sax Wealth Advisors, LLC	7,371	€41.5k	0%	0.01%
0.18%	Raymond Vennare	7,122	€40.1k	70.1%	no data
0.14%	David Smith	5,451	€30.7k	20.3%	no data
0.13%	Northern Trust Global Investments	5,404	€30.5k	30.1%	no data
0.13%	Matthew Hawryluk	5,260	€29.6k	216%	no data
0.099%	Veena Rao-Mirmira	3,974	€22.4k	0%	no data
0.09%	Facet Wealth, Inc.	3,599	€20.3k	0%	no data
0.089%	Robert Myers	3,563	€20.1k	0%	no data
0.069%	Csenge Advisory Group, Llc, Asset Management Arm	2,750	€15.5k	83.3%	no data
0.059%	Pamela Bush	2,369	€13.4k	0%	no data
0.044%	Petredis Investment Advisors LLC	1,750	€9.9k	0%	no data
0.039%	BNY Mellon Asset Management	1,556	€8.8k	0%	no data